Janne Saari
Muita ideoita: Janne
Herzog & de Meuron: Rudin House

Herzog & de Meuron: Rudin House

It’s an old line, but David Skok said it bears repeating: Skok is digital advisor to the editor-in-chief of the Boston Globe, and a former Nieman Fellow. He spent his year at Harvard studying and collaborating with the creator of disruptive innovation theory, Clayton Christensen. They co-authored an article about disruption in the news industry. …

It’s an old line, but David Skok said it bears repeating: Skok is digital advisor to the editor-in-chief of the Boston Globe, and a former Nieman Fellow. He spent his year at Harvard studying and collaborating with the creator of disruptive innovation theory, Clayton Christensen. They co-authored an article about disruption in the news industry. …

How The New York Times is incorporating design into audience research - Columbia Journalism Review

How The New York Times is incorporating design into audience research - Columbia Journalism Review

Can Dogs Smell Cancer?

Can Dogs Smell Cancer?

Will Cancer-Sniffing Dogs Be The Screeners Of The Future? | Huffington Post

Will Cancer-Sniffing Dogs Be The Screeners Of The Future? | Huffington Post

'Groundbreaking' Trial Will Test Cancer-Sniffing Dogs | Huffington Post

'Groundbreaking' Trial Will Test Cancer-Sniffing Dogs | Huffington Post

Will Cancer-Sniffing Dogs Be The Screeners Of The Future? | Huffington Post

Will Cancer-Sniffing Dogs Be The Screeners Of The Future? | Huffington Post

Tumor RNA in platelets may diagnose and classify cancer, identify treatment strategies: Platelet RNA may provide easily accessible 'liquid biopsy' for many types of tumor -- ScienceDaily

Tumor RNA in platelets may diagnose and classify cancer, identify treatment strategies: Platelet RNA may provide easily accessible 'liquid biopsy' for many types of tumor -- ScienceDaily

A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analyzing a sample equivalent to one drop of blood. Using this new method for blood-based RNA tests of blood platelets, researchers have been able to identify cancer with 96 per cent accuracy, scientists report.

A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analyzing a sample equivalent to one drop of blood. Using this new method for blood-based RNA tests of blood platelets, researchers have been able to identify cancer with 96 per cent accuracy, scientists report.

A new method to detect cancer cells in the blood before they settle in the tissue and form a new tumor has been developed by a team of researchers. To date, it has been difficult to detect cancer cells in the blood at an early stage: about one malignant cell is encountered per billion of healthy cells.

A new method to detect cancer cells in the blood before they settle in the tissue and form a new tumor has been developed by a team of researchers. To date, it has been difficult to detect cancer cells in the blood at an early stage: about one malignant cell is encountered per billion of healthy cells.